Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-01-29
2008-01-29
Spector, Lorraine (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S399000, C530S350000, C435S069400, C435S070100, C435S069100, C424S192100, C424S198100
Reexamination Certificate
active
07323446
ABSTRACT:
Polypeptide growth factors, methods of making them, polynucleotides encoding them, antibodies to them, and methods of using them are disclosed. The polypeptides comprise an amino acid segment that is at least 70% identical to residues 52-179 of SEQ ID NO:2 or residues 258-370 of SEQ ID NO:2. Multimers of the polypeptides are also disclosed. The polypeptides, multimeric proteins, and polynucleotides can be used in the study and regulation of cell and tissue development, as components of cell culture media, and as diagnostic agents.
REFERENCES:
patent: 6495668 (2002-12-01), Gilbert et al.
patent: 6706687 (2004-03-01), Eriksson et al.
patent: 2002/0094546 (2002-07-01), Shimkets et al.
patent: 2002/0164710 (2002-11-01), Eriksson et al.
patent: 2003/0049816 (2003-03-01), Baker et al.
patent: WO00/27879 (2000-05-01), None
patent: WO01/00878 (2001-01-01), None
patent: WO01/25437 (2001-04-01), None
patent: WO01/40466 (2001-06-01), None
patent: WO01/55430 (2001-08-01), None
patent: WO01/89450 (2001-11-01), None
National Cancer Institute, Cancer Genome Anatomy Project, Accession No. AA488780, 1997.
Fujiwara et al., Genbank Accession No. D80118, 1995.
Strausberg, Genbank Accession No. AA488780, 1997.
Incyte Clone Information Results, INC1966916, Oct. 17, 1996.
Incyte Clone Information Results, INC2521401, Feb. 4, 1997.
Incyte Clone Information Results, INC2762339, Mar. 10, 1997.
Incyte Clone Information Results, INC2997909, Oct. 6, 1997.
Incyte Clone Information Results, INC3096554, Nov. 17, 1997.
Incyte Clone Information Results, INC6250517, Mar. 1, 2000.
Incyte Clone Information Results, INC6904711, Mar. 1, 2000.
Incyte Clone Information Results, INC6254291, Mar. 1, 2000.
TIGR Tentative Human Consensus Sequence, THC D80118, Jul. 3, 1997.
Robson et al.,Introduction to Proteins and Protein Engineering: 41, 1986.
Bergsten et al.,Nature Cell Biology 3: 512-516, 2001.
LaRochelle et al.,Nature Cell Biology 3: 517-521, 2001.
Tsai et al.,Biochimica et Biophysica Acta 1492:196-202, 2000.
Gilbert Teresa
Gilbertson Debra G.
Hart Charles E.
Sheppard Paul O.
Parker Gary E.
Shafer Shulamith H
Sherbina Nicholas V.
Spector Lorraine
ZymoGenetics Inc.
LandOfFree
Growth factor homolog ZVEGF4 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Growth factor homolog ZVEGF4, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Growth factor homolog ZVEGF4 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2748087